about
Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.[Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal tuberculosis].Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations.Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopyBispectral index in hypercapnic encephalopathy associated with COPD exacerbation: a pilot studyImmune phenotypes in lung cancer patients with COPD: potential implications for immunotherapyEGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
P50
Q40070868-00B083B5-AF95-40D9-9A11-22F401A0E5E2Q50242237-5B8BF393-6CCA-4ED0-844D-CDAF42B3E906Q51476009-0A0086C6-5558-471C-82EB-8AD472172A78Q55212210-6F69B917-ED08-4E07-868C-DDB23F7595F1Q57020386-4FD77B82-969E-479B-8635-5E776A62CCCFQ57491726-578F2DB3-26CC-4946-A29B-381FD79758F8Q91030823-981CD7C0-A8EA-4501-BD39-B3CC1A822B94Q93182436-7BFCC12E-CB99-4F4F-A7FD-CDC7BAF66C0E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Roberto Chalela
@en
Roberto Chalela
@nl
type
label
Roberto Chalela
@en
Roberto Chalela
@nl
prefLabel
Roberto Chalela
@en
Roberto Chalela
@nl
P31
P496
0000-0003-4835-3852